Leqembi and p-tau217: A Blood Test Offers a New Window Into Alzheimer’s
A personal look at what happened to my p-tau217 blood levels after starting Leqembi, and how new research suggests that changes in this Alzheimer’s biomarker may provide an early indication of how patients are responding to treatment.
p-tau217 Blood Test: What Your Result Means
What does your p-tau217 blood test actually mean? Learn what p-tau217 measures, how it relates to beta-amyloid, why laboratory cutoffs differ, and why the number is not a measure of Alzheimer’s severity.
Learn How Alzheimer’s Creeped Into My Brain
Alzheimer's doesn't begin with memory loss. It begins silently 20 to 30 years earlier as changes in beta-amyloid, toxic oligomers, inflammation, and tau gradually damage the brain. This article explains the modern science behind Alzheimer's in clear, understandable language and shows how new blood tests, biomarkers, and treatments like Leqembi are transforming diagnosis, and offering hope for the future.
How to Understand Your Alzheimer's Blood Tests and PET Scan Results
Alzheimer's lab reports can be confusing, filled with unfamiliar numbers and medical terms that leave many patients wondering what they actually mean. I felt the same way after my diagnosis. Over the course of my treatment, I learned how to understand my blood tests and amyloid PET scans, and that knowledge helped me follow my progress and ask better questions. This guide explains the key biomarkers and imaging results in plain English so you can better understand your own Alzheimer's test reports.